Selected research
Market Analysis & Forecast
Global Endostatin Protein Market Analysis and Forecast 2026-2032
Market perspective
The global Endostatin Protein market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Endostatin Protein is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Endostatin Protein is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Endostatin Protein is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Endostatin Protein is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Endostatin Protein include Hengrui Pharma, ZYBio, Sigma-Aldrich, R&D Systems, Prospec, PeproTech, Novus Biologicals, MyBioSource and MedChem Express, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Endostatin Protein, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Endostatin Protein, also provides the sales of main regions and countries. Of the upcoming market potential for Endostatin Protein, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Endostatin Protein sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Endostatin Protein market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Endostatin Protein sales, projected growth trends, production technology, application and end-user industry.
Endostatin Protein Segment by Company
Hengrui Pharma
ZYBio
Sigma-Aldrich
R&D Systems
Prospec
PeproTech
Novus Biologicals
MyBioSource
MedChem Express
Innovative Research
Denovo Biopharma
BioLegend
Endostatin Protein Segment by Type
Natural Endostatin
Recombinant Endostatin
Endostatin Protein Segment by Application
Medical
Pharmaceuticals
Endostatin Protein Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endostatin Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endostatin Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endostatin Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Endostatin Protein in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Endostatin Protein manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endostatin Protein sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Natural Endostatin
- Recombinant Endostatin
Applications
- Medical
- Pharmaceuticals
Companies covered
- Hengrui Pharma
- ZYBio
- Sigma-Aldrich
- R&D Systems
- Prospec
- PeproTech
- Novus Biologicals
- MyBioSource
- MedChem Express
- Innovative Research
- Denovo Biopharma
- BioLegend
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Endostatin Protein Market by Type
- 1.2.1 Global Endostatin Protein Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Natural Endostatin
- 1.2.3 Recombinant Endostatin
- 1.3 Endostatin Protein Market by Application
- 1.3.1 Global Endostatin Protein Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical
- 1.3.3 Pharmaceuticals
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Endostatin Protein Market Dynamics
- 2.1 Endostatin Protein Industry Trends
- 2.2 Endostatin Protein Industry Drivers
- 2.3 Endostatin Protein Industry Opportunities and Challenges
- 2.4 Endostatin Protein Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Endostatin Protein Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Endostatin Protein Revenue by Region
- 3.2.1 Global Endostatin Protein Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Endostatin Protein Revenue by Region (2021-2026)
- 3.2.3 Global Endostatin Protein Revenue by Region (2027-2032)
- 3.2.4 Global Endostatin Protein Revenue Market Share by Region (2021-2032)
- 3.3 Global Endostatin Protein Sales Estimates and Forecasts 2021-2032
- 3.4 Global Endostatin Protein Sales by Region
- 3.4.1 Global Endostatin Protein Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Endostatin Protein Sales by Region (2021-2026)
- 3.4.3 Global Endostatin Protein Sales by Region (2027-2032)
- 3.4.4 Global Endostatin Protein Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Endostatin Protein Revenue by Manufacturers
- 4.1.1 Global Endostatin Protein Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Endostatin Protein Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Endostatin Protein Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Endostatin Protein Sales by Manufacturers
- 4.2.1 Global Endostatin Protein Sales by Manufacturers (2021-2026)
- 4.2.2 Global Endostatin Protein Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Endostatin Protein Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Endostatin Protein Sales Price by Manufacturers (2021-2026)
- 4.4 Global Endostatin Protein Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Endostatin Protein Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Endostatin Protein Manufacturers, Product Type & Application
- 4.7 Global Endostatin Protein Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Endostatin Protein Market CR5 and HHI
- 4.8.2 2025 Endostatin Protein Tier 1, Tier 2, and Tier 3
5 Endostatin Protein Market by Type
- 5.1 Global Endostatin Protein Revenue by Type
- 5.1.1 Global Endostatin Protein Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Endostatin Protein Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Endostatin Protein Revenue Market Share by Type (2021-2032)
- 5.2 Global Endostatin Protein Sales by Type
- 5.2.1 Global Endostatin Protein Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Endostatin Protein Sales by Type (2021-2032) & (kg)
- 5.2.3 Global Endostatin Protein Sales Market Share by Type (2021-2032)
- 5.3 Global Endostatin Protein Price by Type
6 Endostatin Protein Market by Application
- 6.1 Global Endostatin Protein Revenue by Application
- 6.1.1 Global Endostatin Protein Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Endostatin Protein Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Endostatin Protein Revenue Market Share by Application (2021-2032)
- 6.2 Global Endostatin Protein Sales by Application
- 6.2.1 Global Endostatin Protein Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Endostatin Protein Sales by Application (2021-2032) & (kg)
- 6.2.3 Global Endostatin Protein Sales Market Share by Application (2021-2032)
- 6.3 Global Endostatin Protein Price by Application
7 Company Profiles
- 7.1 Hengrui Pharma
- 7.1.1 Hengrui Pharma Company Information
- 7.1.2 Hengrui Pharma Business Overview
- 7.1.3 Hengrui Pharma Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Hengrui Pharma Endostatin Protein Product Portfolio
- 7.1.5 Hengrui Pharma Recent Developments
- 7.2 ZYBio
- 7.2.1 ZYBio Company Information
- 7.2.2 ZYBio Business Overview
- 7.2.3 ZYBio Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 ZYBio Endostatin Protein Product Portfolio
- 7.2.5 ZYBio Recent Developments
- 7.3 Sigma-Aldrich
- 7.3.1 Sigma-Aldrich Company Information
- 7.3.2 Sigma-Aldrich Business Overview
- 7.3.3 Sigma-Aldrich Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Sigma-Aldrich Endostatin Protein Product Portfolio
- 7.3.5 Sigma-Aldrich Recent Developments
- 7.4 R&D Systems
- 7.4.1 R&D Systems Company Information
- 7.4.2 R&D Systems Business Overview
- 7.4.3 R&D Systems Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 R&D Systems Endostatin Protein Product Portfolio
- 7.4.5 R&D Systems Recent Developments
- 7.5 Prospec
- 7.5.1 Prospec Company Information
- 7.5.2 Prospec Business Overview
- 7.5.3 Prospec Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Prospec Endostatin Protein Product Portfolio
- 7.5.5 Prospec Recent Developments
- 7.6 PeproTech
- 7.6.1 PeproTech Company Information
- 7.6.2 PeproTech Business Overview
- 7.6.3 PeproTech Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 PeproTech Endostatin Protein Product Portfolio
- 7.6.5 PeproTech Recent Developments
- 7.7 Novus Biologicals
- 7.7.1 Novus Biologicals Company Information
- 7.7.2 Novus Biologicals Business Overview
- 7.7.3 Novus Biologicals Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Novus Biologicals Endostatin Protein Product Portfolio
- 7.7.5 Novus Biologicals Recent Developments
- 7.8 MyBioSource
- 7.8.1 MyBioSource Company Information
- 7.8.2 MyBioSource Business Overview
- 7.8.3 MyBioSource Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 MyBioSource Endostatin Protein Product Portfolio
- 7.8.5 MyBioSource Recent Developments
- 7.9 MedChem Express
- 7.9.1 MedChem Express Company Information
- 7.9.2 MedChem Express Business Overview
- 7.9.3 MedChem Express Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 MedChem Express Endostatin Protein Product Portfolio
- 7.9.5 MedChem Express Recent Developments
- 7.10 Innovative Research
- 7.10.1 Innovative Research Company Information
- 7.10.2 Innovative Research Business Overview
- 7.10.3 Innovative Research Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Innovative Research Endostatin Protein Product Portfolio
- 7.10.5 Innovative Research Recent Developments
- 7.11 Denovo Biopharma
- 7.11.1 Denovo Biopharma Company Information
- 7.11.2 Denovo Biopharma Business Overview
- 7.11.3 Denovo Biopharma Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Denovo Biopharma Endostatin Protein Product Portfolio
- 7.11.5 Denovo Biopharma Recent Developments
- 7.12 BioLegend
- 7.12.1 BioLegend Company Information
- 7.12.2 BioLegend Business Overview
- 7.12.3 BioLegend Endostatin Protein Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 BioLegend Endostatin Protein Product Portfolio
- 7.12.5 BioLegend Recent Developments
8 North America
- 8.1 North America Endostatin Protein Market Size by Type
- 8.1.1 North America Endostatin Protein Revenue by Type (2021-2032)
- 8.1.2 North America Endostatin Protein Sales by Type (2021-2032)
- 8.1.3 North America Endostatin Protein Price by Type (2021-2032)
- 8.2 North America Endostatin Protein Market Size by Application
- 8.2.1 North America Endostatin Protein Revenue by Application (2021-2032)
- 8.2.2 North America Endostatin Protein Sales by Application (2021-2032)
- 8.2.3 North America Endostatin Protein Price by Application (2021-2032)
- 8.3 North America Endostatin Protein Market Size by Country
- 8.3.1 North America Endostatin Protein Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Endostatin Protein Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Endostatin Protein Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Endostatin Protein Market Size by Type
- 9.1.1 Europe Endostatin Protein Revenue by Type (2021-2032)
- 9.1.2 Europe Endostatin Protein Sales by Type (2021-2032)
- 9.1.3 Europe Endostatin Protein Price by Type (2021-2032)
- 9.2 Europe Endostatin Protein Market Size by Application
- 9.2.1 Europe Endostatin Protein Revenue by Application (2021-2032)
- 9.2.2 Europe Endostatin Protein Sales by Application (2021-2032)
- 9.2.3 Europe Endostatin Protein Price by Application (2021-2032)
- 9.3 Europe Endostatin Protein Market Size by Country
- 9.3.1 Europe Endostatin Protein Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Endostatin Protein Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Endostatin Protein Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Endostatin Protein Market Size by Type
- 10.1.1 China Endostatin Protein Revenue by Type (2021-2032)
- 10.1.2 China Endostatin Protein Sales by Type (2021-2032)
- 10.1.3 China Endostatin Protein Price by Type (2021-2032)
- 10.2 China Endostatin Protein Market Size by Application
- 10.2.1 China Endostatin Protein Revenue by Application (2021-2032)
- 10.2.2 China Endostatin Protein Sales by Application (2021-2032)
- 10.2.3 China Endostatin Protein Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Endostatin Protein Market Size by Type
- 11.1.1 Asia Endostatin Protein Revenue by Type (2021-2032)
- 11.1.2 Asia Endostatin Protein Sales by Type (2021-2032)
- 11.1.3 Asia Endostatin Protein Price by Type (2021-2032)
- 11.2 Asia Endostatin Protein Market Size by Application
- 11.2.1 Asia Endostatin Protein Revenue by Application (2021-2032)
- 11.2.2 Asia Endostatin Protein Sales by Application (2021-2032)
- 11.2.3 Asia Endostatin Protein Price by Application (2021-2032)
- 11.3 Asia Endostatin Protein Market Size by Country
- 11.3.1 Asia Endostatin Protein Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Endostatin Protein Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Endostatin Protein Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Endostatin Protein Market Size by Type
- 12.1.1 SAMEA Endostatin Protein Revenue by Type (2021-2032)
- 12.1.2 SAMEA Endostatin Protein Sales by Type (2021-2032)
- 12.1.3 SAMEA Endostatin Protein Price by Type (2021-2032)
- 12.2 SAMEA Endostatin Protein Market Size by Application
- 12.2.1 SAMEA Endostatin Protein Revenue by Application (2021-2032)
- 12.2.2 SAMEA Endostatin Protein Sales by Application (2021-2032)
- 12.2.3 SAMEA Endostatin Protein Price by Application (2021-2032)
- 12.3 SAMEA Endostatin Protein Market Size by Country
- 12.3.1 SAMEA Endostatin Protein Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Endostatin Protein Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Endostatin Protein Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Endostatin Protein Value Chain Analysis
- 13.1.1 Endostatin Protein Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Endostatin Protein Production Mode & Process
- 13.2 Endostatin Protein Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Endostatin Protein Distributors
- 13.2.3 Endostatin Protein Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst